The concept of perihilar cholangiocarcinoma is valid

British Journal of Surgery

Volumn 96, Issue 8, 2009, Pages 926-934

  Ebata, T ^a   Kamiya, J ^a   Nishio, H ^a   Nagasaka, T ^a   Nimura, Y ^b   Nagino, M ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERIHILAR CHOLANGIOCARCINOMA; PORTAL VEIN; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 68049084770     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6655     Document Type: Article

References (41)

1. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224: 463-473.
2. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 1965; 38: 241-256.
3. Okuda K, Kubo Y, Okazaki N, Arishima T, Hashimoto M. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer 1977; 39: 232-246.
4. Nishio H, Nagino M, Oda K, Ebata T, Arai T, Nimura Y. TNM classification for perihilar cholangiocarcinoma: comparison between 5th and 6th editions of the AJCC/UICC staging system. Langenbecks Arch Surg 2005; 390: 319-327.
5. Sano T, Shimada K, Sakamoto Y, Yamamoto J, Yamasaki S, Kosuge T. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg 2006; 244: 240-247.
6. Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R.What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer 1997; 79: 26-34.
7. Burke EC, Jarnagin WR, Hochwald SN, Pisters PW, Fong Y, Blumgart LH. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998; 228: 385-394.
8. Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 2003; 238: 84-92.
9. Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 2003; 238: 73-83.
10. Isaji S, Kawarada Y, Taoka H, Tabata M, Suzuki H, Yokoi H. Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 1999; 6: 108-116.
11. Ikeyama T, Nagino M, Oda K, Ebata T, Nishio H, Nimura Y. Surgical approach to Bismuth type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Ann Surg 2007; 246: 1052-1057.
12. Nagino M, Kamiya J, Arai T, Nishio H, Ebata T, Nimura Y. 'Anatomic' right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilar cholangiocarcinoma. Ann Surg 2006; 243: 28-32.
13. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 2006; 243: 364-372.
14. Nagino M, Nimura Y, Kamiya J, Kondo S, Kanai M. Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology 1996; 200: 559-563.
15. Bhuiya MR, Nimura Y, Kamiya J, Kondo S, Fukata S, Hayakawa N et al. Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg 1992; 215: 344-349.
16. Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg 2001; 233: 385-392.
17. Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 2003; 238: 720-727.
18. Nimura Y, Hayakawa N, Kamiya J, Maeda S, Kondo S, Yasui A et al. Combined portal vein and liver resection for carcinoma of the biliary tract. Br J Surg 1991; 78: 727-731.
19. Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg 1990; 14: 535-543.
20. Ebata T, Watanabe H, Ajioka Y, Oda K, Nimura Y. Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg 2002; 89: 1260-1267.
21. Ohkubo M, Nagino M, Kamiya J, Yuasa N, Oda K, Arai T et al. Surgical anatomy of the bile ducts at the hepatic hilum as applied to living donor liver transplantation. Ann Surg 2004; 239: 82-86.
22. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG et al. (eds). AJCC Cancer Staging Manual (6th edn). Springer: New York, 2002.
23. Japanese Society of Biliary Surgery. General Rules for Surgical and Pathological Studies on Cancer of Biliary Tract (4th edn). Kanehara: Tokyo, 1997.
24. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215: 31-38.
25. Hamilton SR, Aaltonen LA (eds). Pathology and Genetics of Tumours of the Digestive System. IARC Press: Lyons, 2000.
26. Henson DE, Albores-Saavedra J, Compton CC. Protocol for the examination of specimens from patients with carcinomas of the extrahepatic bile ducts, exclusive of sarcomas and carcinoid tumors: a basis for checklists. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 2000; 124: 26-29.
27. Sakamoto E, Nimura Y, Hayakawa N, Kamiya J, Kondo S,Nagino M et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg 1998; 227: 405-411.
28. Jarnagin WR, Fong Y, DeMatteo RP,Gonen M, Burke EC, Bodniewicz BSJ et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234: 507-517.
29. Dowsett JF, Vaira D, Hatfield AR, Cairns SR, Polydorou A, Frost R et al. Endoscopic biliary therapy using the combined percutaneous and endoscopic technique. Gastroenterology 1989; 96: 1180-1186.
30. Yamanaka N, Okamoto E, Ando T, Oriyama T, Fujimoto J, Furukawa K et al. Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma. Cancer 1995; 76: 2449-2456.
31. Yamamoto M, Takasaki K, Yoshikawa T, Ueno K, Nakano M. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? J Surg Oncol 1998; 69: 162-167.
32. Nakagohri T, Asano T, Kinoshita H, Kenmochi T, Urashima T, Miura F et al. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma. World J Surg 2003; 27: 289-293.
33. Hirohashi K, Uenishi T, Kubo S, Yamamoto T, Tanaka H, Shuto T et al. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2002; 9: 233-236.
34. Okabayashi T, Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T et al. A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 2001; 92: 2374-2383.
35. Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 2003; 10: 288-291.
36. Sano T, Shimada K, Sakamoto Y, Ojima H, Esaki M, Kosuge T. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus. Ann Surg Oncol 2008; 15: 590-599.
37. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33: 1353-1357.
38. Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England andWales 1968-1998. Gut 2001; 48: 816-820.
39. Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 2006; 98: 873-875.
40. Khan SA, Davidson BR, Goldin R, Pereira SP, RosenbergWM, Taylor-Robinson SD et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002; 51(Suppl 6): VI1-VI9.
41. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005; 366: 1303-1314.